These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37293077)

  • 1. Neural Network Models for Sequence-Based TCR and HLA Association Prediction.
    Liu S; Bradley P; Sun W
    bioRxiv; 2023 May; ():. PubMed ID: 37293077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural network models for sequence-based TCR and HLA association prediction.
    Liu S; Bradley P; Sun W
    PLoS Comput Biol; 2023 Nov; 19(11):e1011664. PubMed ID: 37983288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Learning predictive signatures of HLA type from T-cell repertoires.
    Ortega MR; Pogorelyy MV; Minervina AA; Thomas PG; Walczak AM; Mora T
    bioRxiv; 2024 Jan; ():. PubMed ID: 38352609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a novel NFAT-GFP reporter platform useful for the functional avidity maturation of HLA class II-restricted TCRs.
    Fujiki F; Morimoto S; Nishida Y; Tanii S; Aoyama N; Inatome M; Inoue K; Katsuhara A; Nakajima H; Nakata J; Nishida S; Tsuboi A; Oka Y; Oji Y; Sogo S; Sugiyama H
    Cancer Immunol Immunother; 2023 Jul; 72(7):2347-2356. PubMed ID: 36939853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCR meta-clonotypes for biomarker discovery with
    Mayer-Blackwell K; Schattgen S; Cohen-Lavi L; Crawford JC; Souquette A; Gaevert JA; Hertz T; Thomas PG; Bradley P; Fiore-Gartland A
    Elife; 2021 Nov; 10():. PubMed ID: 34845983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
    Duong MN; Erdes E; Hebeisen M; Rufer N
    J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the T-cell receptors utilized for allogeneic HLA-DR recognition: comparison of different responder-cell donors possessing an identical HLA-DR allele.
    Obata F; Tsunoda-Iizuka M
    Scand J Immunol; 1998 Oct; 48(4):364-70. PubMed ID: 9790306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naive and memory T cells TCR-HLA-binding prediction.
    Glazer N; Akerman O; Louzoun Y
    Oxf Open Immunol; 2022; 3(1):iqac001. PubMed ID: 36846560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors.
    Dillard P; Casey N; Pollmann S; Vernhoff P; Gaudernack G; Kvalheim G; Wälchli S; Inderberg EM
    Oncoimmunology; 2021; 10(1):1936757. PubMed ID: 34235003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying the immune interactions underlying HLA class I disease associations.
    Debebe BJ; Boelen L; Lee JC; ; Thio CL; Astemborski J; Kirk G; Khakoo SI; Donfield SM; Goedert JJ; Asquith B
    Elife; 2020 Apr; 9():. PubMed ID: 32238263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key Features Relevant to Select Antigens and TCR From the MHC-Mismatched Repertoire to Treat Cancer.
    Audehm S; Glaser M; Pecoraro M; Bräunlein E; Mall S; Klar R; Effenberger M; Albers J; Bianchi HO; Peper J; Yusufi N; Busch DH; Stevanović S; Mann M; Antes I; Krackhardt AM
    Front Immunol; 2019; 10():1485. PubMed ID: 31316521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural high-avidity T-cell receptor efficiently mediates regression of cancer/testis antigen 83 positive common solid cancers.
    Li Q; Hu W; Liao B; Song C; Li L
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35798537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic mutagenesis of TCR complementarity-determining region 3 residues: a single conservative substitution dramatically improves response to both multiple HLA-DR alleles and peptide variants.
    Brawley JV; Concannon P
    J Immunol; 1999 Nov; 163(9):4946-52. PubMed ID: 10528198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-2-restricted cytolytic T lymphocytes specific for HLA display T cell receptors of limited diversity.
    Casanova JL; Cerottini JC; Matthes M; Necker A; Gournier H; Barra C; Widmann C; MacDonald HR; Lemonnier F; Malissen B; Maryanski JL
    J Exp Med; 1992 Aug; 176(2):439-47. PubMed ID: 1380061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily.
    Lichterfeld M; Williams KL; Mui SK; Shah SS; Mothe BR; Sette A; Kim A; Johnston MN; Burgett N; Frahm N; Cohen D; Brander C; Rosenberg ES; Walker BD; Altfeld M; Yu XG
    Int Immunol; 2006 Jul; 18(7):1179-88. PubMed ID: 16772368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global analysis of HLA-A2 restricted MAGE-A3 tumor antigen epitopes and corresponding TCRs in non-small cell lung cancer.
    Zhang B; Ren Z; Zhao J; Zhu Y; Huang B; Xiao C; Zhang Y; Deng J; Mao L; Tang L; Lan D; Gao L; Zhang H; Chen G; Luo OJ
    Theranostics; 2023; 13(13):4449-4468. PubMed ID: 37649599
    [No Abstract]   [Full Text] [Related]  

  • 17. Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions.
    Robbins PF; Li YF; El-Gamil M; Zhao Y; Wargo JA; Zheng Z; Xu H; Morgan RA; Feldman SA; Johnson LA; Bennett AD; Dunn SM; Mahon TM; Jakobsen BK; Rosenberg SA
    J Immunol; 2008 May; 180(9):6116-31. PubMed ID: 18424733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of TGFβR2(-1) neoantigen-specific HLA-DR4-restricted T cell receptors for cancer therapy.
    Plewa N; Poncette L; Blankenstein T
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA autoimmune risk alleles restrict the hypervariable region of T cell receptors.
    Ishigaki K; Lagattuta KA; Luo Y; James EA; Buckner JH; Raychaudhuri S
    Nat Genet; 2022 Apr; 54(4):393-402. PubMed ID: 35332318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying specificity groups in the T cell receptor repertoire.
    Glanville J; Huang H; Nau A; Hatton O; Wagar LE; Rubelt F; Ji X; Han A; Krams SM; Pettus C; Haas N; Arlehamn CSL; Sette A; Boyd SD; Scriba TJ; Martinez OM; Davis MM
    Nature; 2017 Jul; 547(7661):94-98. PubMed ID: 28636589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.